Study of blood filter after kidney therapy
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study is for adults who are starting continuous kidney replacement therapy (CRRT) for kidney failure. It looks at how well the filter removes waste, and excludes people on ECMO.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are starting or already on continuous kidney replacement therapy (CRRT).
- You are not on ECMO (a heart-lung bypass machine).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether the lifespan (how long they can be used) of dialysis filters can be optimized during continuous kidney dialysis for very sick adults. If successful, it may improve care and use of dialysis supplies for people with dialysis-dependent kidney injury.
This study compares two blood-thinning medications used during continuous dialysis for acute kidney injury: one uses citrate (a chemical that prevents clotting) and the other uses heparin (a standard blood thinner). By looking at how well these treatments work, the study aims to find the safest and most effective way to keep the dialysis filter working.
This study tests a special blood filtration machine (multiFiltratePRO) in children with kidney failure who need continuous dialysis. It aims to see how well the treatment works and if it's safe for younger patients.
This trial compares two types of dialysis (hemodialysis and hemodiafiltration) to see which is better at removing waste from the blood in ICU patients with sudden kidney failure. It may help doctors choose the best treatment for you.
This study compares different types of dialysis to see which removes waste products (uremic toxins) best from the blood. If you have been on dialysis for at least 6 months and use the same filter for a year, this trial may help find a better way to clean your blood.
This study looks at an add-on blood-filter treatment used in the ICU to help remove harmful substances like waste products, inflammation signals, or toxins from the blood. Results may help doctors understand whether this approach improves care and how it should be used.
Hear when a new Renal Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.